FDA releases quarterly list of drugs under safety review

02/17/2010 | Reuters

Novartis' cancer drug Gleevec, Roche Holding's flu drug Tamiflu, and Biogen Idec and Elan's multiple sclerosis drug Tysabri are on a list of drugs under safety investigation by the FDA. The agency said being on the quarterly list "does not mean that FDA has identified a causal relationship between the drug and the listed risk."

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ